Patents by Inventor Markus Zollinger

Markus Zollinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ceramide-analogous metabolites
    Patent number: 8673982
    Abstract: This invention relates to certain ceramide-analogues of FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; fingolimod). In particular, the present invention relates to pharmaceutical compositions comprising these compounds, as well as processes for their preparation and their use in the treatment of autoimmune conditions, such as multiple sclerosis.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: March 18, 2014
    Assignee: Novartis AG
    Inventors: Volker Brinkmann, Guido Jordine, Markus Zollinger, Claudia Sayer
  • AMINOPROPANOL DERIVATIVES
    Publication number: 20120277194
    Abstract: Compounds of formula I: wherein R1, R2, n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: July 11, 2012
    Publication date: November 1, 2012
    Inventors: Rainer ALBERT, Eric FRANCOTTE, Frédéric ZECRI, Markus ZOLLINGER
  • CERAMIDE-ANALOGOUS METABOLITES
    Publication number: 20110306672
    Abstract: This invention relates to certain ceramide-analogues of FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; fingolimod). In particular, the present invention relates to pharmaceutical compositions comprising these compounds, as well as processes for their preparation and their use in the treatment of autoimmune conditions, such as multiple sclerosis.
    Type: Application
    Filed: February 23, 2010
    Publication date: December 15, 2011
    Applicant: NOVARTIS AG
    Inventors: Volker Brinkmann, Guido Jordine, Markus Zollinger, Claudia Sayer
  • AMINOPROPANOL DERIVATIVES
    Publication number: 20110118210
    Abstract: Compounds of formula I: wherein R1, R2, n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: January 28, 2011
    Publication date: May 19, 2011
    Inventors: Rainer ALBERT, Eric Francotte, Frédéric Zecri, Markus Zollinger
  • Aminopropanol derivatives
    Patent number: 7902175
    Abstract: Compounds of formula I: wherein R1, R2, n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Grant
    Filed: February 24, 2009
    Date of Patent: March 8, 2011
    Assignee: Novartis AG
    Inventors: Rainer Albert, Eric Francotte, Frederic Zecri, Markus Zollinger
  • AMINOPROPANOL DERIVATIVES
    Publication number: 20090156556
    Abstract: Compounds of formula I: wherein R1, R2, n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: February 24, 2009
    Publication date: June 18, 2009
    Inventors: Rainer Albert, Eric Francotte, Frederic Zecri, Markus Zollinger
  • Aminopropanol derivatives
    Patent number: 7528120
    Abstract: Compounds of formula I: wherein R1, R2, n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: May 5, 2009
    Assignee: Novartis AG
    Inventors: Rainer Albert, Eric Francotte, Frédéric Zecri, Markus Zollinger